Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial
The National Institutes of Health/National Institute of Allergy and Infectious Diseases. <b>Registration for the COVE Trial. </b> ClinicalTrials.gov ID# NCT04470427.
Authors
- Weiping Deng (ORCID: https://orcid.org/0000-0002-9825-3297)
- Haiyu Zhou (ORCID: https://orcid.org/0000-0002-3328-6792)
- Avika Dixit (ORCID: https://orcid.org/0000-0002-8381-3298)
- Hana M. El Sahly (ORCID: https://orcid.org/0000-0003-0489-0074)
- Eric Chun‐Pu Chu (ORCID: https://orcid.org/0000-0002-0893-556X)
- Joanne E. Tomassini (ORCID: https://orcid.org/0000-0002-9399-2867)
- Jacqueline Miller (ORCID: https://orcid.org/0000-0002-6474-0505)
- Frances Priddy (ORCID: https://orcid.org/0000-0002-2533-3982)
- Holly Janes (ORCID: https://orcid.org/0000-0002-3237-984X)
- Dean A. Follmann (ORCID: https://orcid.org/0000-0003-4073-0393)
- Megan A Berman
- Ian Frank (ORCID: https://orcid.org/0000-0002-7824-0106)
- Colleen F. Kelley (ORCID: https://orcid.org/0000-0001-5611-0119)
- Peter B. Gilbert (ORCID: https://orcid.org/0000-0002-2662-9427)
- Lindsey Robert Baden (ORCID: https://orcid.org/0009-0004-1752-1926)
- Xiaowei Wang (ORCID: https://orcid.org/0000-0002-5430-4777)
- Rituparna Das (ORCID: https://orcid.org/0000-0002-5166-0311)
- Brandon Essink (ORCID: https://orcid.org/0000-0002-7309-228X)
Institutions
- Brigham and Women's Hospital (US)
- Grady Memorial Hospital (US)
- Harvard University (US)
- Emory University (US)
- Baylor College of Medicine (US)
- Fred Hutch Cancer Center (US)
- Grady Health System (US)
- Moderna Therapeutics (United States) (US)
- National Institute of Allergy and Infectious Diseases (US)
- Meridian Clinical Research (US)
- The University of Texas Medical Branch at Galveston (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1093/ofid/ofae689
- Citations
- 7
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases